A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD
Abstract The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic of novel coronavirus disease (COVID-19). The neutralizing monoclonal antibodies (mAbs) targeting the receptor-binding domain (RBD) of SARS-CoV-2 are among the most promising strategies to prevent a...
Main Authors: | Xiaofei Wang, Ao Hu, Xiangyu Chen, Yixin Zhang, Fei Yu, Shuai Yue, Arong Li, Junsong Zhang, Zhiwei Pan, Yang Yang, Yao Lin, Leiqiong Gao, Jing Zhou, Jing Zhao, Fang Li, Yaling Shi, Feng Huang, Xiaofan Yang, Yi Peng, Luoyang Tu, Huan Zhang, Huanying Zheng, Jun He, Hui Zhang, Lifan Xu, Qizhao Huang, Yongqun Zhu, Kai Deng, Lilin Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-04-01
|
Series: | Signal Transduction and Targeted Therapy |
Online Access: | https://doi.org/10.1038/s41392-022-00954-8 |
Similar Items
-
Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2
by: Yu Liang, et al.
Published: (2022-02-01) -
Mutated trimeric RBD vaccines: a platform against variants of concern
by: Belén Aparicio, et al.
Published: (2023-04-01) -
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
by: Qingtai Liang, et al.
Published: (2022-04-01) -
Molecular Basis of the Differentiation and Function of Virus Specific Follicular Helper CD4+ T Cells
by: Qizhao Huang, et al.
Published: (2019-02-01) -
Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
by: Changcai Teng, et al.
Published: (2022-12-01)